Rheumatology

SRI’s understanding of the rheumatology market is unmatched. SRI team leaders have been conducting rheumatology market research for longer than anyone else, even before the launch of the first biologic treatment for rheumatoid arthritis. SRI also has tremendous experience in ankylosing spondylitis, psoriatic arthritis, Juvenile RA, and osteoarthritis. The types of studies include tracking studies, patient chart pulls, conjoint studies, market segmentations, market maps, messaging, regulatory studies, KOL research, launch tracking, Big Data Analytics, and more, both in the US and globally.